Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study

INTRODUCTION: The metabolic syndrome (MetS) may contribute to the excess cardiovascular burden observed in rheumatoid arthritis (RA). The prevalence and associations of the MetS in RA remain uncertain: systemic inflammation and anti-rheumatic therapy may contribute. Methotrexate (MTX) use has recent...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Toms, Tracey E, Panoulas, Vasileios F, John, Holly, Douglas, Karen MJ, Kitas, George D
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2009
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2745792/
https://ncbi.nlm.nih.gov/pubmed/19607680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar2765
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky